Challenges and future directions of potential natural products leads against 2019-nCoV outbreak | Zendy

Meirambek Ospanov | Zendy; Francisco León | Zendy; Janar Jenis | Zendy; Ikhlas A. Khan | Zendy; Mohamed A. Ibrahim | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Challenges and future directions of potential natural products leads against 2019-nCoV outbreak

Author(s) -

Meirambek Ospanov,

Francisco León,

Janar Jenis,

Ikhlas A. Khan,

Mohamed A. Ibrahim

Publication year - 2020

Publication title -

current plant biology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.51

H-Index - 16

ISSN - 2214-6628

DOI - 10.1016/j.cpb.2020.100180

Subject(s) - covid-19 , outbreak , coronavirus , medicine , virology , drug , intensive care medicine , disease , infectious disease (medical specialty) , pharmacology

Except for Remdesivir® no other drug or vaccine has yet been approved to treat the coronavirus disease (COVID-19) caused by the virus known as, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Remdesivir® an small molecule and nucleic acid analogue, it is used to treat adults and children with laboratory confirmed COVID-19, only administrated in hospital settings. Small molecules and particularly natural products count for almost fifty percent of the commercially available drugs, several of them are marketed antiviral agents and those can be a potential agent to treat COVID-19 infections. This short review rationalized different key natural products with known activity against coronaviruses as potential leads against COVID-19.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research